• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Chinese population study shows high prevalence of elevated cardiovascular disease risk and low utilization of pharmacotherapy

byKathleen W. HigginsandDeepti Shroff Karhade
February 21, 2019
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this national screening project, around 10% of middle-aged Chinese subjects were found to be at “high risk” for cardiovascular disease.

2. Aspirin and statins were only used by 0.6% and 2.4% of high-risk individuals, respectively.

Evidence Rating Level: 3 (Average)

Study Rundown: A 2015 study showed that cardiovascular disease (CVD) is now the leading cause of death in China, accounting for 40% of all deaths.  This statistic is likely to rise further, given the country’s rapidly aging population and increasing rates of risk factors like diabetes, hypertension, and smoking.  This study was the result of a national screening effort to understand the prevalence of CVD in Chinese adults and to identify modifiable risk factors that can be targeted in future health programs.  Of the 1.7 million adults surveyed, 9.5% met criteria for being at “high risk” for cardiovascular disease.  Common modifiable risk factors included hypertension, dyslipidemia, diabetes, smoking, and alcohol.  However, only a small fraction of high risk adults received aspirin, statins, or antihypertensive medication. Compared to previous studies, this study covered a considerably larger cross section of the Chinese population, including patients from all 31 provinces of the country.  However, it relied upon a “convenience sampling strategy,” which raises concerns for sampling bias.  It is also important to note that definition of CVD risk was determined by international organizations, and has not been validated for the Chinese population

Click to read the study in Annals of Internal Medicine

Click to read the accompanying editorial in Annals of Internal Medicine

Relevant Reading: China cardiovascular diseases report 2015: a summary

RELATED REPORTS

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

The majority of FDA-approved drug trials recruit from low- and middle-income countries

In-Depth [cross-sectional study]: This study evaluated the prevalence and risk factors for CVD in a population of 1.7 million Chinese adults from across China.  Patients were selected by convenience, and were omitted from analysis if they had pre-existing CVD or if their data were not complete.  The authors used a risk prediction algorithm developed by the World Health Organization and the International Society for Hypertension, which take into account age, sex, smoking, systolic blood pressure, diabetes, and total cholesterol.  Demographic factors associated with high CVD risk included Han ethnicity, current alcohol use, and insurance status.  Having a higher education, being married, or working as a farmer were associated with decreased risk.  Among patients identified as “high risk,” around 96.2% had co-morbid hypertension, 54.9% had diabetes, 29.7% smoked, and 18.1% drank alcohol.  Notably, only about 43.1% of patients with hypertension and 30.6% of patients were aware of their diagnosis.   When all different subpopulations were pooled, only 0.5% of high risk patients were taking statins (CI95: 0.5% to 0.6%) and only 2.4% were taking aspirin (CI95 2.3% to 2.5%).  In certain subgroups, these rates were as high as 4% and 6%, respectively.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular disease
Previous Post

The KATHERINE trial: trastuzumab emtansine more effective than trastuzumab alone for treating residual HER2-positive breast cancer

Next Post

Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

RelatedReports

Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
Higher parental monitoring linked to safer sex in teens
Cardiology

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

December 22, 2022
Population-based risk factors and geographical trends identified for vitiligo
Cardiology

The majority of FDA-approved drug trials recruit from low- and middle-income countries

December 9, 2022
Appropriate use criteria for angiography may frequently miss obstructive coronary artery disease
Cardiology

Bivalirudin during and post-percutaneous coronary intervention reduces bleeding and mortality compared to heparin monotherapy

December 6, 2022
Next Post
Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

Herpes zoster vaccine not cost-effective for 50 year-old adults

New herpes zoster vaccine predicted to be more cost effective than predecessor  

2 Minute Medicine Rewind February 18, 2019

Quick Take: Association between Periprocedural Neutropenia and Early Infection-related Chest Port Removal

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options